Woman outside looking up towards trees

Hereditary ovarian cancer

Find out what hereditary ovarian cancer is, how gene variants are passed on, and who can be tested for hereditary ovarian cancer (germline testing).

On this page:

Watch our video to find out more about hereditary ovarian cancer, genetic variants and genetic testing for ovarian cancer.

If you have a diagnosis of ovarian cancer, it’s common to think about what caused it. You may worry that your family members are at risk of developing cancer. 

Cancer is a common illness. It’s not unusual for more than one person in a family to have cancer. Sometimes different types of cancer can happen in the same family. In most cases this happens by chance. But in some families, there may be an inherited genetic cause that increases the chance of certain cancers, such as ovarian cancer. 

What is hereditary ovarian cancer?

Hereditary ovarian cancer is when the cancer runs in families. Up to 20 per cent (1 in every 5) of ovarian cancer cases happen because of a genetic variant that increases the risk of developing ovarian cancer. Genetic variants can be inherited and passed on through families. You may hear hereditary ovarian cancer called familial ovarian cancer.

Some types of ovarian cancer are more likely to be caused by an inherited gene variant. The most common type of ovarian cancer, high-grade serous epithelial, is most strongly linked to genetic variants. Other types, like mucinous or germ cell ovarian cancers are less commonly caused by inherited gene changes. 

If you’re diagnosed with ovarian cancer, you may be offered genetic testing to check whether the cancer is caused by a genetic variant. 

How does hereditary ovarian cancer develop?

Your body is made up of tiny building blocks called cells. In each cell is a chemical called DNA (deoxyribonucleic acid). DNA acts as the cell’s instruction manual. It tells the cell how to work and behave.

Sections of DNA make up genes. Your genes are instructions for different parts of your body. For example, you have a gene for the colour of your eyes. Genes also tell your cells:

  • what type of cell to be

  • how to behave and grow

  • when to die. 

Sometimes genes can have small changes in their DNA. These are called gene variants. You may also hear them called pathogenic variants, mutations, faulty genes or disease-causing alterations

Some gene variants don’t affect your body. But others can stop a cell from working properly now or in the future. 

Certain gene variants can increase your chance of developing some types of cancer, including ovarian cancer. This doesn’t mean you will get cancer, but it means the chance of it is higher than someone without the gene variant. 

Genetic testing and hereditary ovarian cancer guide 2025

Genetic testing and hereditary ovarian cancer guide

Read or order our guide about genetic testing and hereditary ovarian cancer for free.

How are gene variants passed on?

Cancer can run through families in gene variants that are passed on. You have two copies of each gene. One is passed down (inherited) from your mum and one from your dad. Like genes, a gene variant can also be passed down from your parents. These are called inherited gene variants

If one of your parents has a gene variant there’s a 50 per cent (1 in 2) chance they will pass it on to you. If you inherit a gene variant, there’s a 50 per cent (1 in 2) chance you will pass it on to each child that you have. 

If you don’t inherit a gene variant, there’s no chance that you can pass it on to your own children.

Who can be tested for hereditary ovarian cancer (germline testing)?

In England, Wales and Northern Ireland

You will be offered genetic testing if you’re diagnosed with one of the following types of ovarian cancer: 

In Scotland

You will be offered access to genetic testing if you’re diagnosed with: 

Woman and her daughters sitting on bench arm in arm

Genetic testing with epithelial ovarian cancer

In 2024, The National Institute for Health and Care Excellence (NICE) published a new guideline (NG241). It recommends offering genetic testing to anyone with epithelial ovarian cancer. When we last updated our information about genetic testing (November 2025), genetics centres across the UK are planning how to offer genetic testing for anyone with any type of epithelial ovarian cancer. Ask your treatment team what’s currently available where you live.

Woman and her daughters standing talking

Which genes are tested?

Variants in the BRCA1 or BRCA2 genes cause most hereditary ovarian cancers. About 15 per cent (15 in every 100) of those who develop ovarian cancer have a variant in either their BRCA1 or BRCA2 gene. Variants in other genes also increase the chance of developing ovarian cancer.

Genetic testing with a family history of ovarian cancer

Genetic testing is based on the type of cancer you have and your family history. Your treatment team can tell you which gene variants they're testing for. 

If you have one of the types of ovarian cancer mentioned above, you will always be offered testing for these genes even if you have no family history of ovarian cancer. 

If you don't have one of the ovarian cancer types mentioned above but you have a family history of ovarian cancer, speak to your treatment team or clinical genetics team about what testing is available for the type of ovarian cancer that you have. 

Who is offered testing for other gene variants?

You may not be able to have genetic testing due to the type of cancer you have. But it’s important to talk to your treatment team to find out if it’s something you could have.

You will be offered a test for other gene variants if you have one of the following types of ovarian cancer:

  • ovarian Sertoli-Leydig cell tumour (SLCT)

  • small cell carcinoma of the ovary, hypercalcaemic type (SCCOHT)

  • ovarian sex cord tumour with annular tubules (SCTAT)

  • embryonal rhabdomyosarcoma of the ovary

  • ovarian gynandroblastoma. 

If you have a family history of breast cancer, bowel cancer or Lynch syndrome you may be offered genetic testing for other variants as well. 

Communities with a higher risk of having inherited genetic variants

Anyone in any family can inherit a gene variant. But gene variants are more common in some communities than others. These communities are called at-risk populations. 

Gene variants are more likely in communities that have been separate to other communities due to geography or culture. For example, people from an Ashkenazi Jewish background are about five times more likely to have a BRCA1 or BRCA2 gene variant. This is compared to people in the general population. 

At the time we published this information (November 2025), the NICE guideline NG241 recommends genetic testing for anyone with one or more grandparent from one of the following communities:

  • Ashkenazi Jewish
  • Sephardi Jewish
  • Greenlander.

People from these communities are more at risk of developing hereditary ovarian and/or breast cancer than people from the general population. Genetic testing is recommended even if you have no family or personal history of cancer.

In England

The NHS offers a BRCA1 and BRCA2 gene test if you have one or more Jewish grandparent of any type of Jewish origin. Find out more.

In Wales, Scotland and Northern Ireland

Genetic testing for specific communities with no family or personal history of cancer isn’t currently available. But this is likely to change in future. Ask your treatment team what’s currently available where you live.

Rachel and Val Target Ovarian Cancer nurse advisers

Our support line is open Monday-Friday, 9am–5pm


Last reviewed: November 2025

Next review: November 2028

We are PIF TICK accredited. That means you can trust that our information is based on the latest evidence, regularly updated and easy to follow. To learn more about our review process, take a look at our information standards

 

 

 

 

 

References

Below is a sample of the references used in our genetic testing and hereditary ovarian cancer information. If you'd like more information about the sources we use, please email us at [email protected]

  • Chandrasekaran, D., Sobocan, M., Blyuss, O., et al (2021). Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST Study. Cancers, 13(17), 4344. Available at: 10.3390/cancers13174344 [Accessed November 2025]

  • NICE. Ovarian cancer: identifying and managing familial and genetic risk. NICE guideline [NG241] Published: 21 March 2024. Available from: nice.org.uk/guidance/ng241 [Accessed November 2025]